COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
The present invention is directed to therapeutic compounds which have dual activity as agonists of GPR119 and inhibitors of DPP-IV and are useful for the treatment of metabolic disorders including type II diabetes.
-
Page/Page column 55-56
(2009/04/25)
More Articles about upstream products of 1131872-19-9